This message was sent to ##Email##
|
|
|
|
|
Modern Healthcare
The CMS has finalized a long-awaited rule that will overhaul managed Medicaid, which has not been updated in a decade.
The sweeping 1,425-page rule, which was proposed last May, caps insurer profits, requires states to more rigorously supervise the adequacy of plans' provider networks, encourages states to establish quality rating systems for plans, allows more behavioral healthcare in institutional settings and promotes the growth of managed long-term care. But the CMS deferred to state control for several issues.
READ MORE
MedPage Today
A few days before attendees at the annual meeting of the American Association for Cancer Research (AARC) heard a high-profile lament about the "marginalization" of basic science at the expense of translational research, Stand Up To Cancer launched the latest phase of its collaborative science model — Catalyst.
AACR has served as Stand Up's scientific partner since its inception in 2008. The cancer research and awareness effort is an initiative of the Entertainment Industry Foundation, the charitable arm of the film and television industry that has funded 19 scientific "dream teams," two translational research teams, and 36 individual innovative research grants, including 10 new recipients named at the annual meeting.
READ MORE
| |
SPONSORED CONTENT | Advertisement
|
|
Promoted by
|
|
|
|
 |
ACS
There is still time to register for the NAPBC Best Practices Conference, May 13-14, in Orlando. Breast program leaders and care team members from 15 NAPBC-accredited breast centers will share innovative and efficient methodologies that have been successfully implemented in breast programs across the country, and will offer attendees tools for adoption of these best practices in their own centers. Review the updated agenda.
Continuing Education (CE)
The National Cancer Registrars Association (NCRA) Program Recognition Committee has determined Preconference Workshop: Accreditation and Standards Review program supports 3.25 CE hours. The endorsement period for this program will run from May 13, 2016 through May 13, 2019.
The NCRA Program Recognition Committee has determined NAPBC Best Practices Conference program supports 6.25 CE hours. The endorsement period for this program will run from May 14, 2016 through May 14, 2019.
READ MORE
Cure
While the only potentially curative therapy for patients with advanced myelofibrosis is an allogeneic stem cell transplant, an option unavailable for many patients, the treatment landscape for the disease is rapidly changing. Efforts such as the COMFORT-I and -II studies are proving which agents may or may not be effective for myelofibrosis, while other studies are looking at the aspects that make for a successful for stem cell transplant.
READ MORE
Medical News Today
Researchers have developed a small, implantable device for delivering chemotherapy drugs directly to pancreatic tumors. Tests in mice showed it was up to 12 times more effective than giving the drugs intravenously, which is how most patients receive them.
READ MORE
| |
SPONSORED CONTENT | Advertisement
|
|
Promoted by
|
|
|
|
 |
The 2016 Commission on Cancer (CoC) Annual Conference provides a comprehensive look at CoC standards and the National Cancer Data Base (NCDB) tools and resources. On June 1 and 2, the CoC Program: Pathway to Quality Cancer Care will focus on the CoC Standards and the value of various roles on the cancer committee, guiding participants toward a first-rate quality cancer care program. The NCDB Workshop: Utilizing the NCDB for Quality Improvement on June 3 will provide an in-depth look at the use of the NCDB tools as well as best practices to maximize your cancer program's data. Developed by CoC and NCDB staff and committee leadership, these programs address a cancer program's common questions and concerns regarding CoC standards and compliance as well as the skills and knowledge needed to lead quality improvement initiatives using NCDB tools.
Medscape
The lifetime costs associated with the treatment of cancers induced by the ionizing radiation in CT imaging over just one year in the United States add up to hundreds of millions of dollars, new research suggests.
READ MORE
CBS News
Cancer patients know chemotherapy can be a life-saver, but the side effects are notorious. One common complaint is that the treatment leaves them feeling foggy-headed and forgetful, unable to concentrate or focus as well as they used to. It's been nicknamed "chemo brain."
READ MORE
If you are a Cancer Liaison Physician, plan to join us at a special CoC-CLP Breakfast from 6:30–7:30 a.m. on
Monday, June 6 at the Hyatt Regency McCormick Place, Chicago. To register, send your name and email address to clp@facs.org by May 20.
Cure
Women can now get a better reading of their risk of developing breast cancer, thanks to the addition of three biological markers to conventional breast cancer risk models. The improvement of detection was laid out in a report presented at the AAC 2016 Annual Conference.
READ MORE
|
|
Advertisement
 |
|
For the past 22 years, EduCare's mission has been to support Healthcare Professionals in educating breast cancer patients. We strive to offer products that are patient-friendly and up-to-date. Patient education increases compliance, reduces time constraints and promotes a partnership between patient and healthcare providers.
|
|
|
|
|
Advertisement
 |
|
Specialty Practice Management is a complete front- and back-office solution that offers a rapid return on your investment and improved satisfaction among your staff. Practices with 10 or fewer providers turn to this comprehensive solution to manage self-pay accounts and eliminate common mistakes.
|
|
|
|
ACS
Nutrition is important for surgical patients. Its role as part of the surgical process is not a new concept, however, there's an ongoing discussion of the role of the surgeon in the nutritional health of the patient and how to best educate patients about nutrition. Proper nutrition before and after an operation is one of the most common topics of concern for patients.
READ MORE
Medscape
Results from the I-SPY 2 trial show that a new presurgery (neoadjuvant) combination of trastuzumab emtansine (T-DM1; Kadcyla, Genentech, Inc) and pertuzumab (Perjeta, Genentech, Inc) — both targeting HER2 — was significantly better at achieving a pathologic complete response compared with the standard therapy of paclitaxel (multiple brands) and trastuzumab (Herceptin, Genentech, Inc) in women with HER2+ invasive breast cancer.
READ MORE
ACS
June 5 marks the 29th Annual National Cancer Survivors Day, which brings cancer survivors together to show that there is life after receiving a diagnosis of cancer. The Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC) encourage your program to observe this day and use it as an opportunity to display/promote your CoC and NAPBC accreditation status. To help you promote this event within your program and the community, the CoC and the NAPBC have developed a poster that you can download and print. Programs that hold CoC accreditation or have both CoC and NAPBC accreditations can access the poster by going to CoC Datalinks and clicking on Marketing Resources. For programs that are solely NAPBC accredited, please use the link to the Marketing Resources website provided in your performance report email notification. For more information, contact srubin@facs.org.
Medical News Today
For some people, hepatitis B is a short illness, but for others, it can become long term or chronic and lead to serious liver problems, including cirrhosis and liver cancer. Now, new research finds the risk of liver cancer persists even after the virus is cleared, suggesting people who have had the illness should continue to be monitored.
READ MORE
ASCO
On April 25, 2016, the U.S. Food and Drug Administration approved cabozantinib (CABOMETYX®, Exelixis, Inc.) for the treatment of advanced renal cell carcinoma in patients who have received prior anti-angiogenic therapy.
The approval was based on a randomized study in which patients with advanced renal cell carcinoma who had received prior anti-angiogenic therapy received either cabozantinib 60 mg orally once daily or everolimus 10 mg orally once daily.
READ MORE
Breast Cancer News
A protein found mainly in cartilage tissue, called the Cartilage Oligomeric Matrix Protein, is present at high levels in patients with a poor breast cancer prognosis, and in animal studies contributed to a faster tumor growth and metastasis, Lund University researchers reported. The findings indicate that COMP has the potential to become a biomarker for more aggressive breast cancer.
The study, "Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer," was published in Oncogene.
READ MORE
For additional information, please complete the mailing list request form.
|
|
|
Advertisement
Advertisement
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
